Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DMC Global (BOOM) Reports Q4 Earnings: What Key Metrics Have to Say
DMC Global (BOOM) Reports Q4 Earnings: What Key Metrics Have to Say

DMC Global (BOOM) reported $143.53 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 5.8%. EPS of -$0.50 for the same period compares to $0.09 a year

Compared to Estimates, Skyward (SKWD) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Skyward (SKWD) Q4 Earnings: A Look at Key Metrics

Skyward Specialty Insurance (SKWD) reported $385.59 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 26.7%. EPS of $1.17 for the same period compares

Compared to Estimates, ProAssurance (PRA) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, ProAssurance (PRA) Q4 Earnings: A Look at Key Metrics

ProAssurance (PRA) reported $271.56 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 5.6%. EPS of $0.82 for the same period compares to $0.36 a year

Compared to Estimates, BioMarin (BMRN) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, BioMarin (BMRN) Q4 Earnings: A Look at Key Metrics

BioMarin Pharmaceutical (BMRN) reported $874.57 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 17%. EPS of $0.46 for the same period compares to

Skyward Specialty Insurance (SKWD) Q4 Earnings and Revenues Surpass Estimates
Skyward Specialty Insurance (SKWD) Q4 Earnings and Revenues Surpass Estimates

Skyward Specialty Insurance (SKWD) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $0.8 per share a year

Ultra Clean Holdings (UCTT) Misses Q4 Earnings and Revenue Estimates
Ultra Clean Holdings (UCTT) Misses Q4 Earnings and Revenue Estimates

Ultra Clean Holdings (UCTT) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.51 per share a year ago

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates

Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.6 per share a year ago

V2X (VVX) Tops Q4 Earnings and Revenue Estimates
V2X (VVX) Tops Q4 Earnings and Revenue Estimates

V2X (VVX) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.33 per share a year ago. These figures are

Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates

Si-Bone (SIBN) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.11 per share a year ago. These figures are

Paymentus (PAY) Q4 Earnings and Revenues Surpass Estimates
Paymentus (PAY) Q4 Earnings and Revenues Surpass Estimates

Paymentus (PAY) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.13 per share a year ago. These figures

Offerpad Solutions Inc. (OPAD) Reports Q4 Loss, Lags Revenue Estimates
Offerpad Solutions Inc. (OPAD) Reports Q4 Loss, Lags Revenue Estimates

Offerpad Solutions Inc. (OPAD) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.63 per share a year ago. These

ProAssurance (PRA) Q4 Earnings and Revenues Surpass Estimates
ProAssurance (PRA) Q4 Earnings and Revenues Surpass Estimates

ProAssurance (PRA) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.36 per share a year ago. These

Ryman Hospitality Properties (RHP) Q4 FFO and Revenues Beat Estimates
Ryman Hospitality Properties (RHP) Q4 FFO and Revenues Beat Estimates

Ryman Hospitality Properties (RHP) came out with quarterly funds from operations (FFO) of $2.38 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to FFO of $2.15 per

Myriad Genetics (MYGN) Q4 Earnings and Revenues Surpass Estimates
Myriad Genetics (MYGN) Q4 Earnings and Revenues Surpass Estimates

Myriad Genetics (MYGN) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.03 per share a year

Quaker Chemical (KWR) Lags Q4 Earnings Estimates
Quaker Chemical (KWR) Lags Q4 Earnings Estimates

Quaker Chemical (KWR) came out with quarterly earnings of $1.65 per share, missing the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.33 per share a year ago. These

Innovex International (INVX) Lags Q4 Earnings Estimates
Innovex International (INVX) Lags Q4 Earnings Estimates

Innovex International (INVX) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.47 per share a year ago

MediaAlpha, Inc. (MAX) Q4 Earnings Beat Estimates
MediaAlpha, Inc. (MAX) Q4 Earnings Beat Estimates

MediaAlpha, Inc. (MAX) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.08 per share a year ago. These

JBT Marel (JBTM) Q4 Earnings and Revenues Beat Estimates
JBT Marel (JBTM) Q4 Earnings and Revenues Beat Estimates

JBT Marel (JBTM) came out with quarterly earnings of $1.98 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $1.7 per share a year ago. These figures

Hims & Hers Health, Inc. (HIMS) Surpasses Q4 Earnings Estimates
Hims & Hers Health, Inc. (HIMS) Surpasses Q4 Earnings Estimates

Hims & Hers Health, Inc. (HIMS) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.11 per share a year ago

Innovative Industrial Properties (IIPR) Q4 FFO and Revenues Top Estimates
Innovative Industrial Properties (IIPR) Q4 FFO and Revenues Top Estimates

Innovative Industrial Properties (IIPR) came out with quarterly funds from operations (FFO) of $1.88 per share, beating the Zacks Consensus Estimate of $1.81 per share. This compares to FFO of $2.22

Claritev Corporation (CTEV) Reports Q4 Loss, Tops Revenue Estimates
Claritev Corporation (CTEV) Reports Q4 Loss, Tops Revenue Estimates

Claritev Corporation (CTEV) came out with a quarterly loss of $4.88 per share versus the Zacks Consensus Estimate of a loss of $3.96. This compares to a loss of $5.14 per share a year ago. These

HealthStream (HSTM) Tops Q4 Earnings and Revenue Estimates
HealthStream (HSTM) Tops Q4 Earnings and Revenue Estimates

HealthStream (HSTM) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.16 per share a year ago. These

Great Lakes Dredge & Dock (GLDD) Q4 Earnings and Revenues Beat Estimates
Great Lakes Dredge & Dock (GLDD) Q4 Earnings and Revenues Beat Estimates

Great Lakes Dredge & Dock (GLDD) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.29 per share a year ago

DMC Global (BOOM) Reports Q4 Loss, Beats Revenue Estimates
DMC Global (BOOM) Reports Q4 Loss, Beats Revenue Estimates

DMC Global (BOOM) came out with a quarterly loss of $0.5 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to earnings of $0.09 per share a year ago. These figures are

BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates
BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates

BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.92 per share a year ago